Clinical Trial

Coenzyme Q10 for Gulf War Illness: A Replication Study

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-07-16; most recent amendment 2026-04-27.
Status change: Not Yet Recruiting → Recruiting 2024-09-17
Trial Details
NCT Number NCT06515184
Lead Sponsor University of California, San Diego
Collaborators: United States Department of Defense
Conditions Gulf War Syndrome, Persian Gulf Syndrome, Mitochondrial Disorder, Respiratory Chain
Enrollment 192 participants
Start Date 2024-09-13
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-01